Brachytherapy Alone for Intermediate-Risk Prostate Cancer Brachytherapy Alone for Intermediate-Risk Prostate Cancer

Patients with favorable intermediate-risk prostate cancer can be treated with radioactive-seed brachytherapy alone and thus be spared additional late toxicity associated with the usually standard delivery of external-beam radiation first.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news